Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,150 | -10,443 | -4,459 | -3,322 | -1,784 |
| Other Working Capital | -250 | -568 | -647 | -473 | -721 |
| Other Operating Activity | 199 | 6,348 | 1,579 | 1,364 | 875 |
| Operating Cash Flow | $-1,201 | $-4,662 | $-3,527 | $-2,430 | $-1,630 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 7,895 | 3,469 | 349 | 3 |
| Other Financing Activity | -331 | 280 | -134 | -22 | 0 |
| Financing Cash Flow | $-331 | $8,176 | $3,335 | $327 | $3 |
| Beginning Cash Position | 6,347 | 2,833 | 2,833 | 2,833 | 2,833 |
| End Cash Position | 4,815 | 6,347 | 2,642 | 731 | 1,206 |
| Net Cash Flow | $-1,532 | $3,514 | $-191 | $-2,103 | $-1,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,201 | -4,662 | -3,527 | -2,430 | -1,630 |
| Free Cash Flow | -1,201 | -4,662 | -3,527 | -2,430 | -1,630 |